International Congress on Structural Epilepsy & Symptomatic Seizures

back

ILAE Curriculum Learning Objectives addressed by this course

• 1.1.1 Describe the major etiologies for epilepsy (i.e. structural, genetic, infectious, metabolic, immune, and neurodegenerative) (L1)
• 1.1.2 Describe the common structural etiologies
• 1.1.4 Describe the common infectious causes of epilepsy, including geographical impacts (e.g. bacterial, fungal, viral, parasites) (L2)
• 1.1.6 Describe the common immune causes of epilepsy
• 1.1.7 Describe the common neurodegenerative causes of epilepsy
• 1.7.1 Accurately distinguish acute symptomatic seizures from epilepsy (L1)
• 1.7.2 Correctly distinguish between focal and generalized epilepsies and recognize epileptic encephalopathies (L1)
• 1.7.3 Correctly diagnose and classify focal epilepsies (L2)
• 1.9 Identify patients at high risk of cardiac death: recognize semiology, risk factors and initial management of high risk of cardiac death (L1)
• 3.1.3 Demonstrate knowledge regarding the adverse effects of antiepileptic drugs (L1)
• 3.2.4 Communicate information regarding the antiepileptic drug regimen (L1)
• 3.2.5 Recommend second- and third-line treatments as necessary (L2)
• 3.3.3 Define treatment strategies considering issues specific to the elderly (L2)
• 3.3.6 Define treatment strategies for infectious causes of epilepsy and seizures (L1)
• 3.3.7 Define treatment strategies for immune mediated causes of epilepsy and seizures (L2)
• 3.5.1 Identify patients who are drug resistant according to the current ILAE definition (L1)
• 6.2.1 Diagnose somatic comorbidities, such as those related to epilepsy treatment, causes of epilepsy, or common associated conditions (L2)
• 6.2.2 Appropriately manage and advise regarding somatic comorbidities (L2)
• 6.2.3 Adjust anti-seizure treatment as required by common somatic comorbidities (L2)
• 7.2.1 Demonstrate working knowledge of epileptogenesis (L3)
• 7.3.1 Demonstrate awareness of animal models for focal and generalized epilepsies (L3)